Searched for
SEVELAMER CARBONATE
Lupin gains on USFDA nod to market Sevelamer CarbonateAccording to data for September 2021 released by IQVIA MAT September, Sevelamer Carbonate for oral suspension had estimated annual sales of...- Stocks in the news: HP Adhesives, RIL, Aster DM, Lupin, IDBI Bank and RBL BankHP Adhesives, the adhesive and sealant company will be listed today as the company raised Rs 125.96 crore via its IPO between December 15-1...
- Lupin gets USFDA nod for generic productAs per IQVIA MAT September 2021 data, Sevelamer Carbonate for Oral Suspension had estimated annual sales of USD 51.7 million in the US.
- Lupin gets USFDA nod to market generic Sevelamer Carbonate tabletsThe product is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on...
- Dr Reddy's launches oral suspension drug in the US marketThe newly launched product is in the strengths of 0.8 g and 2.4 g packets, and is a therapeutic equivalent generic version of Renvela (seve...
- Cipla gets USFDA nod for generic version of Renvela tabletsThe approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.
- Dr Reddy’s Labs climbs after launch of generic Sevelamer carbonate tablets in USShares of the company opened at Rs 2,406 and touched a high and low of Rs 2,415 and Rs 2,355, respectively, in trade so far.
- Sensex adds 266 points, Nifty at 9,870; Nifty PSU Bank lone sectoral loserNifty50 was firm at 9,871, up 82 points or 0.84 per cent around 12:50 pm (IST).
- Top stocks in focus on 3 October 2017Here is a list of top stocks that are likely to be in focus in today's trading session.
- Aurobindo Pharma gets USFDA nod to market kidney ailment drugAurobindo Pharma has a total of 331 ANDA approvals (294 final nod, including 16 from Aurolife Pharma LLC and 37 tentative approvals) from t...
- Market Now: ITC, HUL among most active stocks in terms of volumeIn the Nifty50 pack, 38 stocks were trading in green, while 13 stocks were in red.
- Market Now: Pharma index top sectoral gainer; Aurobindo, Cipla gainBenchmark indices started the day on a firm note following firm global cues.
- Sensex, Nifty end lower on subdued global cues; RIL gains 2%In the sectoral landscape, BSE Realty index gained the most at 2.16 per cent.
- Aurobindo Pharma gets USFDA nod for oral suspensionSevelamer Carbonate oral suspension is indicated for the control of serum phosphorus in patients with chronic kidney disease (CKD) on dialy...
Load More
